NCT06712706Active, not recruiting
Effect of Feeding Jejunostomy on Sarcopenia in Patients With Esophageal Cancer
Effect of Feeding Jejunostomy Placement on Sarcopenia in Patients With Advanced Stages of Esophageal Cancer in Curate Cancer Treatment
Source: ClinicalTrials.gov · Last updated 23 Apr 2026
Brief summary (registry, in English)
Participants were diagnosed with esophageal cancer needing chemo- or radiochemotherapy before the potentially curing surgery consisting of esophagectomy. At the time of diagnosis, in all participants, a laparoscopy to complete staging was performed. In some patients, a feeding jejunostomy tube (FJT) was placed at the time of staging laparoscopy; in others, the FJT was placed at the time of esophagectomy. A common risk factor for higher morbidity and mortality is sarcopenia, a condition associated with low skeletal muscle. This study aims to determine whether the timing of the FJT placement affects the progress of sarcopenia.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 60 (actual)
- First submitted
- 26 Nov 2024
- Start date
- 30 Nov 2024
- Primary completion date
- 31 Jan 2025
- Lead sponsor
- Stefan Gutknecht
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06712706
What you commit to
- Study type: Observational
- Participants enrolled: 60
- From 30 Nov 2024 to the primary completion date, 31 Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Insufficient data for analysis
- Written rejection of general consent
Who the study is looking for
- Adult patients aged 18 years and above at the time of diagnosis.
- Advanced-stage esophageal cancer or cancer of the esophageal junction and treated with curative intent, including neoadjuvant treatment.
- Patients who received an FJT either before neoadjuvant treatment or during definitive surgery.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Stadtspital Zürich Coordinator of this site? Confirm its status | Zurich | Switzerland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.